ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ONCR Stock Ownership Breakdown

NASDAQ : ONCR

Oncorus, Inc.

$0.13

-0.004-3.08%

Open: 2:55 PM

Not Actively Trading

68.33

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ONCR Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

N/A

Short % of Float

N/A

Short % of Shares Outstanding

Institutional Ownership

About N/A of shares are held by financial institutions. MPM ASSET MANAGEMENT LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in Oncorus, Inc. is owned by the company. BIOIMPACT CAPITAL LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Sep 30, 2023	MPM ASSET MANAGEMENT LLC	0%	0	-	-2.85M	-100.00%
Sep 30, 2023	BIOIMPACT CAPITAL LLC	0%	0	-	-2.38M	-100.00%
Sep 30, 2023	YOUR ADVOCATES LTD., LLP	0%	100	3	0	0

ONCR Insiders

Among the ONCR insiders holding of N/A of the stake in company, MPM SUNSTATES FUND, L.P., 10 percent owner, holds the largest shares of 2.85M. MPM BIOVENTURES 2014, L.P., 10 percent owner, is the second largest ONCR insider with ownership of 2.85M shares. EVNIN LUKE, , stands third with possession of 2.49M shares of that stake.

Insiders	Designation	Shares Held
MPM SUNSTATES FUND, L.P.	10 percent owner	2.85M
MPM BIOVENTURES 2014, L.P.	10 percent owner	2.85M
EVNIN LUKE		2.49M
UBS ONCOLOGY IMPACT FUND L.P.	10 percent owner	2.38M
GADICKE ANSBERT	10 percent owner	2.38M
FLYNN JAMES E	director	284.7K
WANSTALL RICK	CFO and Treasurer	51K
QUEVA CHRISTOPHE	CSO and SVP, Research	47.63K
HARBIN STEPHEN	COO and Chief of Staff	15K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 30, 2022	FLYNN JAMES E	SALE	0.27	15.22K	4.11K	284.7K
Dec 29, 2022	FLYNN JAMES E	SALE	0.26	15.54K	4.04K	299.92K
Dec 28, 2022	FLYNN JAMES E	SALE	0.25	6.1K	1.52K	315.46K
Dec 27, 2022	FLYNN JAMES E	SALE	0.27	7.14K	1.93K	321.55K
Dec 22, 2022	FLYNN JAMES E	SALE	0.28	909	254.52	328.69K
Dec 21, 2022	FLYNN JAMES E	SALE	0.30	1.51K	453.9	329.6K
Dec 20, 2022	FLYNN JAMES E	SALE	0.31	1.62K	500.96	331.11K
Dec 19, 2022	FLYNN JAMES E	SALE	0.29	10.93K	3.17K	332.73K
Dec 15, 2022	FLYNN JAMES E	SALE	0.39	339	132.21	343.66K
Dec 14, 2022	FLYNN JAMES E	SALE	0.38	943	358.34	343.99K
Dec 13, 2022	FLYNN JAMES E	SALE	0.41	230	94.3	344.94K
May 25, 2022	WANSTALL RICK	PURCHASE	1.20	3.78K	4.53K	51K
May 20, 2022	WANSTALL RICK	PURCHASE	1.20	1.61K	1.93K	47.22K
May 19, 2022	WANSTALL RICK	PURCHASE	1.29	5K	6.45K	45.61K
May 17, 2022	WANSTALL RICK	PURCHASE	1.20	1	1.2	40.61K
May 13, 2022	WANSTALL RICK	PURCHASE	1.15	3.9K	4.48K	19.99K
May 12, 2022	WANSTALL RICK	PURCHASE	1.08	14.09K	15.22K	16.09K
Nov 16, 2021	HARBIN STEPHEN	PURCHASE	5.78	15K	86.7K	15K
Jun 02, 2021	QUEVA CHRISTOPHE	SALE	16.66	10.66K	177.53K	47.63K
Jun 01, 2021	QUEVA CHRISTOPHE	SALE	16.69	12.9K	215.28K	58.28K
Apr 30, 2021	QUEVA CHRISTOPHE	SALE	16.76	800	13.41K	35.62K
Apr 28, 2021	QUEVA CHRISTOPHE	SALE	15.22	17.99K	273.81K	59.18K
Apr 27, 2021	QUEVA CHRISTOPHE	SALE	15.00	211	3.17K	77.17K
Apr 26, 2021	QUEVA CHRISTOPHE	SALE	15.00	54	810	77.38K
Apr 06, 2021	QUEVA CHRISTOPHE	SALE	15.01	5.3K	79.55K	77.43K
Feb 17, 2021	FLYNN JAMES E	PURCHASE	19.00	32.88K	624.8K	345.17K
Oct 06, 2020	GADICKE ANSBERT	PURCHASE	15.00	151.22K	2.27M	2.38M
Oct 06, 2020	EVNIN LUKE	PURCHASE	15.00	151.23K	2.27M	2.49M
Oct 06, 2020	FLYNN JAMES E	PURCHASE	15.00	109.61K	1.64M	312.28K
Oct 06, 2020	MPM SUNSTATES FUND, L.P.	PURCHASE	15.00	173.78K	2.61M	2.85M
Oct 06, 2020	UBS ONCOLOGY IMPACT FUND L.P.	PURCHASE	15.00	151.22K	2.27M	2.38M
Oct 06, 2020	MPM BIOVENTURES 2014, L.P.	PURCHASE	15.00	173.78K	2.61M	2.85M

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter